Sara A. Byron

Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma

Hung Huynh, Van Chanh Ngo, Joseph Fargnoli et al. · Clinical Cancer Research · 2008 · 220 citations · Full text

FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features

Sara A. Byron, Michael G. Gartside, Matthew A. Powell et al. · PLoS ONE · 2012 · 185 citations · Full text

Gynecology, Pathology, Fgfr2 Point Mutations +17

Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation

Sara A. Byron, Michael G. Gartside, Candice L. Wellens et al. · Cancer Research · 2008 · 149 citations · Full text

The N550K/H Mutations in FGFR2 Confer Differential Resistance to PD173074, Dovitinib, and Ponatinib ATP-Competitive Inhibitors

Sara A. Byron, Huaibin Chen, Andreas Wortmann et al. · Neoplasia · 2013 · 132 citations · Full text

A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium

Sabine Mueller, Payal Jain, Winnie S. Liang et al. · International Journal of Cancer · 2019 · 127 citations